Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on August 28, 2026

Aug. 28, 2026

Healthy Aging Focus of 11th Annual Knock Out Opioid Abuse Day

Indeterminate GlobeNewswire

Aug. 28, 2026

CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026

Indeterminate GlobeNewswire

Aug. 28, 2026

NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger

Indeterminate GlobeNewswire

Aug. 28, 2026

Silberstein & Miklos, P.C. (ASK4SAM) Expands Focus on Brooklyn Medical Malpractice, Surgical Errors, Misdiagnosis & Medical Negligence Cases

Indeterminate GlobeNewswire

Aug. 28, 2026

Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions

Indeterminate GlobeNewswire

Aug. 28, 2026

University Findings Undermine Core Electrical Theory Behind Electroshock Therapy—Prompting Citizens Commission on Human Rights International to Renew Its Call for a Ban

Indeterminate GlobeNewswire

Aug. 28, 2026

Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center

Indeterminate GlobeNewswire

Aug. 28, 2026

INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Aug. 28, 2026

New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients

Indeterminate GlobeNewswire

Aug. 28, 2026

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

Indeterminate GlobeNewswire

Aug. 28, 2026

Glucose Health, Inc. (OTCID: GLUC) Appoints Consumer Products Industry Veteran John Duffy as Chief Executive Officer to Accelerate Growth, Elevate Brand Leadership, and Maximize Long-Term Shareholder Value

Indeterminate GlobeNewswire

Aug. 28, 2026

Minerva Neurosciences to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire

Aug. 28, 2026

ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split

Indeterminate GlobeNewswire

Aug. 28, 2026

Advocates to hold nationwide Day of Action for federal action to stop two-tier, American-style health care

Indeterminate GlobeNewswire

Aug. 28, 2026

Micron Biomedical Honored with Georgia Life Sciences' Prestigious Phoenix Award for Transformative Research

Indeterminate GlobeNewswire

Aug. 28, 2026

Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines

Indeterminate GlobeNewswire

Aug. 28, 2026

XORTX Announces Termination and Postponement of Investor Relations Program

Indeterminate GlobeNewswire

Aug. 28, 2026

Avricore Grants Options

Indeterminate GlobeNewswire

Aug. 28, 2026

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy 

Indeterminate GlobeNewswire

Aug. 28, 2026

Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome

Indeterminate GlobeNewswire